The medical packaging film market is expected to grow at a CAGR of 6.07% over the forecast period to reach a total market size of US$8,132.406 million by 2025, increasing from US$5,710.362 million in 2019. As with most other packaged goods, pharmaceuticals need reliable and speedy packaging solutions that deliver a combination of product protection, quality, tamper evidence, patient comfort, and security needs. Increasing availability for biotechnology-based injectable drugs is fueling the demand for medical packaging films. Since these drugs are heat sensitive, they are unable to withstand the high heat of terminal stabilization processes. Growing healthcare and the pharmaceutical sector is the major driving factor that is boosting the medical packaging films market growth. According to the International Trade Administration (ITA), the U.S Department of Commerce, the biopharmaceutical industry accounted for more than $1.3 trillion in economic output, representing 4% of total U.S output in 2015.
Increasing investment in the health care sector
Increasing investment in the pharmaceutical and healthcare sector leads to the growing adoption of medical packaging films in the health care sector during the forecast period. For instance, according to Canadian Institute for Health Information, $228.1 billion was spent on health care in Canada in 2016 which represent about 11 percent of Canada economy or roughly around $6299 per Canadian, moreover between 2001 and 2016 expenditure by the provincial government on healthcare has increased by nearly 116.4 percent (in nominal terms).
Rising government initiative
The government in many countries is investing in the development of a technologically advanced healthcare system which is expected to drive the growth of the market in the coming years. For instance, in South Korea more than half of the total healthcare spending is covered by the national government and state governments, thus improving the affordability of various healthcare services among individuals. National Healthcare Insurance (NHI) covers nearly half of the entire healthcare expenditures in this country. National Health Insurance Program (NHIP), which covers nearly all non-elective procedures, covers around 96% of the overall population in South Korea. Also according to data from the Australian Institute of Health and Welfare, the Australian Government, the country spent around $181 billion on healthcare which was around 6% higher than the previous year. What makes it even more impressive is that more than two-thirds of the overall healthcare spending is funded by the Australian government along with governments of states and territories. Medicare Benefits Scheme (MBS) and the Pharmaceutical Benefits Scheme (PBS) launched by the federal government subsidizes primary care providers besides providing funds to states to ensure the affordability of various healthcare services among citizens. Both publicly financed health insurance and private health insurance have been further improving the affordability of various healthcare services among people. Such policies attract private players’ investment in the medical equipment and packaging industry thus propelling the growth of the market over the next five years.
By material, polypropylene is holding a significant share in the market
Polypropylene as a film material is fast gaining traction in the pharmaceutical packaging industry. It is steadily replacing PVC owing to its eco-friendly nature and good moisture-barrier properties. In developed regions such as Europe, PP is used as a replacement for PVC on account of legislation related to the incineration of PVC. In the pharmaceutical industry, PP blister packs are extensively used as it provides good barrier protection from moisture. Continued investments and launches in polypropylene have supported the growth of its demand in blister packaging. For instance, leading Russian Company SIBUR has introduced new packaging applications with polypropylene incorporating Millad NX 8000 that are suitable for blister packaging used in the pharmaceutical industry.
The Asia Pacific is driving the growth of the market during the forecast period
By geography, the medical packaging film market is segmented as North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. The medical packaging film market in the Asia Pacific is estimated to hold a significant share in 2019 and is anticipated to grow exponentially on account of rising health awareness coupled with increasing investment by both public and private players in the region. Simultaneously, the region is the home of the world’s largest pharmaceutical packaging companies and with the availability of raw materials and low cost of production, the market is anticipated to witness substantial growth in the Asia Pacific region. The North American and European region is also expected to provide good growth opportunities on account of the rising shift of medicine packaging from bottles to films and growing regulation related to single-dose packaging is poised to augment the market growth in the region.
Prominent key market players in the Indian medical packaging films market include Amcor, DuPont, Berry Global Group, 3M, Amcor, and Honeywell International LLC among others. Major players in this market are focusing on strategic acquisitions, collaborative partnerships, product launches, and joint ventures as a part of their growth strategies in order to provide better services to them. For instance, recently, Tekni-Plex acquired three manufacturing facilities from Amcor's Flexible Packaging that is located in the United States that provides sterilizable medical device packaging substrates to pharmaceutical companies. Also, in 2018, Amcor Limited invested nearly US$25 million for the up-gradation of the Madison manufacturing facility which provides a packaging solution for medical and other pharmaceutical products. In addition, in August 2018, Berry Global Group acquired Laddawn Inc one of the leading manufacturers of blown polyethylene bags and films. Major players in the global medical packaging film market have been covered along with their relative competitive position and strategies. The report analysis also mentions recent deals and investments of different market players over the last year. The company profiles section provides a detailed business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the global medical packaging film market.
|Market size value in 2019||US$5,710.362 million|
|Market size value in 2025||US$8,132.406 million|
|Growth Rate||CAGR of 6.07% from 2019 to 2025|
|Forecast Unit (Value)||USD Million|
|Segments covered||Material, Type, Application, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Amcor, DuPont, Berry Global Group, 3M, Amcor, Honeywell International LLC, Wipak Oy, Renolit Medical, Glenroy, Inc., Dunmore Corporation|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What will be the medical packaging film market size by 2025?
A1. The medical packaging film market is expected to reach a total market size of US$8,132.406 million in 2025.
Q2. What factors are anticipated to drive the medical packaging film market growth?
A2. Increasing availability for biotechnology-based inject-able drugs is fueling the demand for medical packaging films.
Q3. What is the size of medical packaging film market?
A3. Medical Packaging Film market was valued at US$5,710.362 million in 2019.
Q4. What are the growth prospects for medical packaging film market?
A4. The medical packaging film market is expected to grow at a CAGR of 6.07% over the forecast period.
Q5. Which region holds the largest market share in medical packaging film market?
A5. The medical packaging film market in the Asia Pacific is estimated to hold a significant share in 2019 and is anticipated to grow exponentially on account of rising health awareness coupled with increasing investment by both public and private players in the region.
Berry Global Group
Honeywell International LLC
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.